burosumab

Italy

Drugs containing this active substance

  • CRYSVITA

    It is used for the treatment of X-linked hypophosphatemia (XLH) in children, adolescents, and adults, and for the treatment of tumor-induced osteomalacia (TIO) in cases where the causative tumor cannot be identified or successfully removed.

    Form: solution for injection

    Active substance Dosage
    burosumab -

    ATC: M05BX05

    Manufacturer: KYOWA KIRIN HOLDINGS B.V.